Learn more

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST BIOORGANICHESKOJ KHIMII IM AKADEMIKOV

Overview
  • Total Patents
    55
  • GoodIP Patent Rank
    26,654
  • Filing trend
    ⇩ 50.0%
About

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST BIOORGANICHESKOJ KHIMII IM AKADEMIKOV has a total of 55 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2014. It filed its patents most often in Russian Federation. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SAN DIEGO STATE UNIV SDSU FOUNDATION DBA SAN DIEGO STATE UNIV RESEARCH FOUNDATION, MELBOURNE HEALTH and MAXYGEN INC.

Patent filings in countries

World map showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST BIOORGANICHESKOJ KHIMII IM AKADEMIKOVs patent filings in countries
# Country Total Patents
#1 Russian Federation 55

Patent filings per year

Chart showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST BIOORGANICHESKOJ KHIMII IM AKADEMIKOVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chumakov Stepan Petrovich 10
#2 Kravchenko Yuliya Evgenevna 10
#3 Frolova Elena Ivanovna 10
#4 Gabibov Aleksandr Gabibovich 10
#5 Smirnov Ivan Vitalevich 9
#6 Kirpichnikov Mikhail Petrovich 7
#7 Mokrushina Yuliana Anatolevna 6
#8 Dolgikh Dmitrij Aleksandrovich 5
#9 Ovchinnikova Tatyana Vladimirovna 4
#10 Lezhnin Yurij Nikolaevich 4

Latest patents

Publication Filing date Title
RU2730897C1 Method of using recombinant proteins sars-cov-2 as part of a test system for elisa test with determining igm, igg, iga class antibody levels in blood serum/plasma of covid-19 patients
RU2734649C1 Peptide having lynx1 protein activity (embodiments), pharmaceutical composition for treating anxiety disorders and depression or correction of cognitive disorders in neurodegenerative diseases, containing said peptide, and method of treating and correcting said disorders
RU2723084C1 Methylotrophic yeast strain pichia pastoris yst-ppic9pgapzalpha-short_htfng, producing recombinant human transferrin containing amino acid substitutes n413d and n611d
RU2732835C1 Recombinant plasmid dna of pfuse/scfv47fc, intended for producing single-chain antibody fused with human immunoglobulin constant fragment inactivating paraoxone pesticide
RU2702661C1 Peptide exhibiting antibacterial and antitumour properties
RU2727059C1 Method of suppressing growth of tumours with genetically modified version of trail cytokine
RU2721273C1 Nikomycin peptide from nereid nicomache minor possessing antimicrobial and antitumour activity
RU2721129C1 Use of recombinant analogue of water-soluble domain of lynx1 protein for cell growth inhibition by carcinoma
RU2698725C1 Method of producing lignan, having analgesic action
RU2716975C1 Recombinant plasmid dna coding fusion protein l-hep, escherichia coli strain producer of said protein and method of producing recombinant protein
RU2700452C1 Recombinant plasmid dna of ptrx-tevrs-pth coding a hybrid protein capable of proteolytic splitting to form a fragment of endogenous human parathyroid hormone (1-34), an escherichia coli bl21(de3)/ptrx-tevrs-pth strain - producer of said protein and a method of producing recombinant pth (1-34)
RU2714380C1 Method for producing cytotoxic t-lymphocytes expressing chimeric receptors
RU2731988C2 Composition for preventing aggregation and higher homogeneity of culture, increasing productivity of recombinant proteins producing cell lines
RU2725493C2 System for stable expression of tumor-associated antigens based on lentiviral vector
RU2720912C1 Method for producing model immortalized cell line containing reconstructed b-cell receptor of non-hodgkin lymphomas
RU2687435C1 Method of producing human recombinant anti-tumour protein dr5-b
RU2694598C1 Cell line hufshkkc6, producer of recombinant human follicle stimulating hormone (fsh) and method for producing fsh using said line
RU2698140C2 Method for calibrating the volume of solution for microinjection into pre-ovulatory mouse oocytes
RU2682039C1 Peptide, possessing anti-tumor and anti-metastatic activity, and finished dosage form based thereon
RU2677296C2 Peptide having therapeutic effect against alzheimer's disease